Open AccessSeverity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality
Author(s) -
Sanjaya K. Satapathy,
Christian Kuntzen,
He Qiu,
Yu Jiang,
Henry C. Bodenheimer,
Nitzan Roth,
Tai-Ping Lee,
Jamie S. Hirsch,
Arvind J. Trindade,
David Bernstein
Publication year - 2021
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 102
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0000000000002055
Subject(s) - medicine , diabetes mellitus , comorbidity , severity of illness , bilirubin , liver disease , disease , mortality rate , gastroenterology , endocrinology
Liver chemistry abnormalities (LCA) are common in patients with coronavirus disease 2019 (COVID-19), but their causes and clinical impact have not been adequately studied. We assessed the associations between LCA and clinical characteristics, inflammatory serum markers, in-hospital mortality.